Olaf Stuve, M.D., Ph.D. Titles and Appointments Chief of Neurology, Dallas Veterans Affairs Medical Center Professor School Graduate School Department Neurology Graduate Programs Immunology Biography Joined UT Southwestern: 2005 Dr. Olaf Stuve is a Professor in the Department of Neurology at UT Southwestern Medical Center, Head of the MS/ Neuroimmunology section, and Chief of Neurology at the VA North Texas Health Care System/ Dallas VA Medical Center. At the Dallas VA Medical Center, he attends to US veterans with multiple sclerosis (MS) and other neurological disorders. Research: Dr. Stuve has been the Principal Investigator and site Principal Investigator for numerous clinical trials. Dr. Stuve also runs a research laboratory at UT Southwestern, studying the differential molecular requirements for bone-marrow-derived leukocytes to cross the blood-brain barrier or other biological barriers that provide immune privilege for the central nervous system (CNS). He is also exploring molecular and cellular differences between bone-marrow-derived myeloid cell subsets and CNS-intrinsic microglia, and the potential pathogenic role of innate immune cells in early and late MS. Furthermore, Dr. Stuve's research interests include molecular and cellular markers of autoimmunity, and experimental therapies for autoimmune disorders and has numerous ongoing collaborations with national and international investigators. Dr. Stuve’s research has been supported by grants from the Department of Veterans Affairs (VA), the National Multiple Sclerosis Society (NMSS), the Deutsche Forschungsgemeinschaft (DFG), and Boehringer Ingelheim Fonds. He has published over 300 research articles, review articles, editorials, and book chapters, and has given over 200 invited presentations. Dr. Stuve has served on numerous editorial boards of medical and scientific journals and has been a member of the National Institutes of Health (NIH), NMSS, and VA study sections. Dr. Stuve is a past associate editor of JAMA Neurology and a past steering committee member of the Immune Tolerance Network (ITN). Trainee Education: Dr. Stuve has received numerous clinical teaching awards. Dr. Stuve has mentored undergraduate students, graduate students, medical students, residents, post-doctoral fellows, and faculty. Awards: He is an elected member of the Alpha Omega Alpha (AOA) Honor Medical Society, and he is a recipient of a Clinical Scientist Development Award from the Doris Duke Charitable Foundation and a Grant for Multiple Sclerosis Innovation (GMSI) from Merck KGaA. Dr. Stuve was elected Top Provider in Neurology at the VA North Texas Health Care System repeatedly by physician peers across medical and surgical specialties, and he has been listed in D Magazine's Best Doctors list. Background: Dr. Stuve received his medical degree from the Free University of Berlin, completed a medical doctoral thesis in physiology at the Max Delbruck Center for Molecular Medicine in Berlin magna cum laude, and earned a Ph.D. in immunology in the Department of Clinical and Experimental Immunology at Maastricht University. He completed a transitional internship at the University of Cape Town, and a preliminary internship and neurology residency at the University of Washington in Seattle. Dr. Stuve also received postdoctoral fellowship training in neuroimmunology at McGill University in Montreal, and the University of California, San Francisco (UCSF). Education Medical School Freie University Berlin (1993), Medicine Medical School Max Delbruck Center for Molecu (1994), Physiology Graduate School Maastricht University (1994), Immunology Research Interest Experimental therapies for autoimmune disorders Immune tolerance Molecular and cellular markers of autoimmunity Publications Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial Spain RI, Paz Soldán MM, Freedman MS, Repovic P, Solomon AJ, Rinker JR, Wallin MT, Haselkorn JK, Stuve O, Gross RH, Waslo CS, Hildebrand A, Morris CD, Mitchell J, Turner AP, Schwartz DL, Metz J, Rooney W Neurology 2026 Jan 106 e214454 Remyelination therapies are achievable in clinical practice—No Shirani A, Stuve O Multiple Sclerosis Journal 2026 Jan 32 57-59 Clinical and radiological outcomes of directed treatment transitions from Gilenya®to generic fingolimod Patel MA, Punnen TG, Shan KS, McCreary M, Wright CM, Munoz SB, Hardeman P, Burgess KW, Greenberg B, Horton LA, Sguigna PV, Tardo LM, Stüve O, Okuda DT Multiple Sclerosis Journal 2026 The Knowns and Unknowns of Prion Protein in Immune Modulation and the Pathogenesis of Neuroautoimmune Diseases Abbasi Kasbi N, Stuve O Current Treatment Options in Neurology 2025 Dec 27 Tau in Multiple Sclerosis: A Review of Therapeutic Potential Hoehne C, Stuve O, Stopschinski BE Current Treatment Options in Neurology 2025 Dec 27 Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System Shirani A, Goldlust SA, Stuve O Therapeutic Advances in Neurological Disorders 2025 Nov 18 Multiple sclerosis treatments a review of current biomedical engineering approaches Mohseni SO, Au KM, Issa W, Ruan L, Stuve O, Wang AZ Biomaterials 2025 Feb 313 Glucagon‑like peptide‑1 receptor agonists in multiple sclerosis: therapeutic promise, challenges, and future directions Shirani A, Stuve O Expert Opinion on Investigational Drugs 2025 34 929-941 Beyond the Single-Disease Paradigm—Why Distinctions in Multiple Sclerosis Still Matter Shirani A, Stuve O JAMA neurology 2025 Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BA, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D The Lancet Neurology 2024 Nov 23 1119-1132 Results 1-10 of 313 1 2 3 4 5 Next Last Honors & Awards D Magazine's Best Doctors listNeurology (2019) D Magazine's Best Doctors listNeurology (2018) Visiting ProfessorshipUniversity Erlangen, Germany (2017) Alpha Omega Alpha (ΑΩΑ) Honor Medical SocietyHonorary member, Texas Gamma Chapter (2013) Clinical Teaching Award NeurologyUniversity of Texas Southwestern Medical School, Class of 2012 (2011) Clinical Teaching Award NeurologyUniversity of Texas Southwestern Medical School, Class of 2011 (2010) Clinical Scientist Development AwardDoris Duke Charitable Foundation (2009) Clinical Teaching Award NeurologyUniversity of Texas Southwestern Medical School, Class of 2008 (2007) Postdoctoral scholarshipBoehringer Ingelheim Fonds (2001) Advanced postdoctoral fellowship grantNational Multiple Sclerosis Society (NMSS) (2000) H.-L. Teuber priceThe Montreal Neurological Institute, McGill University, Montreal (1996) Postdoctoral fellowship grantDeutsche Forschungsgemeinschaft (DFG), Germany (1995) Magna cum laude M.D. thesisFree University of Berlin, Germany (1994) Professional Associations/Affiliations Department of Neurology, UT Southwestern (2005) Neurology Section, VA North Texas Health Care System (2005)